MP4CO, a pegylated hemoglobin saturated with carbon monoxide, is a modulator of HO-1, inflammation, and vaso-occlusion in transgenic sickle mice
Transgenic sickle mice expressing βS hemoglobin have activated vascular endothelium in multiple organs that exhibits enhanced expression of NF-ĸB and adhesion molecules and promotes microvascular stasis in sickle, but not normal, mice in response to hypoxia/reoxygenation (H/R), or heme. Induction of...
Gespeichert in:
Veröffentlicht in: | Blood 2013-10, Vol.122 (15), p.2757-2764 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2764 |
---|---|
container_issue | 15 |
container_start_page | 2757 |
container_title | Blood |
container_volume | 122 |
creator | Belcher, John D. Young, Mark Chen, Chunsheng Nguyen, Julia Burhop, Kenneth Tran, Phuc Vercellotti, Gregory M. |
description | Transgenic sickle mice expressing βS hemoglobin have activated vascular endothelium in multiple organs that exhibits enhanced expression of NF-ĸB and adhesion molecules and promotes microvascular stasis in sickle, but not normal, mice in response to hypoxia/reoxygenation (H/R), or heme. Induction of heme oxygenase-1 (HO-1) or administration of its products, carbon monoxide (CO) or biliverdin, inhibits microvascular stasis in sickle mice. Infusion of human hemoglobin conjugated with polyethylene glycol and saturated with CO (MP4CO) markedly induced hepatic HO-1 activity and inhibited NF-ĸB activation and H/R-induced microvascular stasis in sickle mice. These effects were mediated by CO; saline or MP4 saturated with O2 (MP4OX) had little to no effect on H/R-induced stasis, though unmodified oxyhemoglobin exacerbated stasis. The HO-1 inhibitor, tin protoporphyrin, blocked MP4CO protection, consistent with HO-1 involvement in the protection afforded by MP4CO. MP4CO also induced nuclear factor-erythroid 2 p45-related factor 2 (Nrf2), an important transcriptional regulator of HO-1 and other antioxidant genes. In a heterozygous (hemoglobin-AS) sickle mouse model, intravenous hemin induced cardiovascular collapse and mortality within 120 minutes, which was significantly reduced by MP4CO, but not MP4OX. These data demonstrate that MP4CO induces cytoprotective Nrf2 and HO-1 and decreases NF-ĸB activation, microvascular stasis, and mortality in transgenic sickle mouse models.
•Carbon monoxide treatment of murine sickle mice can ameliorate inflammation and vaso-occlusion.•MP4CO induces heme oxygenase-1 and Nrf2 to mediate these salutatory effects. |
doi_str_mv | 10.1182/blood-2013-02-486282 |
format | Article |
fullrecord | <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4067504</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497120497861</els_id><sourcerecordid>S0006497120497861</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-300468777d9edb691a49c8773225e92bf5846df3c76de3fb4979182adacf870e3</originalsourceid><addsrcrecordid>eNp9UctuFDEQtCIQWQJ_EEX-gBjaj3ldIkWrQJCClgOcLY_ds2syY6_s2U3yF3wyThYCXDi1uuyqru4i5JTDO85b8b4fY3RMAJcMBFNtLVpxRBa8Ei0DEPCCLACgZqpr-DF5nfN3AK6kqF6RYyE7aFXdLsiPz1_UcnVODd3i-mE0Mzq6wSmux9j7QLOZd-kJvPPzhlqT-hjoFEO89w7Pqc-FOUW3K8yYaBzo9YrxgodhNNNkZh9DEQ-O7k2OLFo77nLBygc6JxPyGoO3NHt7OyKdvMU35OVgxoxvf9UT8u3D1dflNbtZffy0vLxhVtVyZhKg-G-axnXo-rrjRnW29FKICjvRD1XZzw3SNrVDOfTlCl25mnHGDm0DKE_IxUF3u-sndBZD8TPqbfKTSQ86Gq__fQl-o9dxrxXUTQWqCKiDgE0x54TDM5eDfkxIPyWkHxPSIPQhoUI7-3vuM-l3JH-MYdl-7zHpbD0Gi84ntLN20f9_wk9eU6U-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>MP4CO, a pegylated hemoglobin saturated with carbon monoxide, is a modulator of HO-1, inflammation, and vaso-occlusion in transgenic sickle mice</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Belcher, John D. ; Young, Mark ; Chen, Chunsheng ; Nguyen, Julia ; Burhop, Kenneth ; Tran, Phuc ; Vercellotti, Gregory M.</creator><creatorcontrib>Belcher, John D. ; Young, Mark ; Chen, Chunsheng ; Nguyen, Julia ; Burhop, Kenneth ; Tran, Phuc ; Vercellotti, Gregory M.</creatorcontrib><description>Transgenic sickle mice expressing βS hemoglobin have activated vascular endothelium in multiple organs that exhibits enhanced expression of NF-ĸB and adhesion molecules and promotes microvascular stasis in sickle, but not normal, mice in response to hypoxia/reoxygenation (H/R), or heme. Induction of heme oxygenase-1 (HO-1) or administration of its products, carbon monoxide (CO) or biliverdin, inhibits microvascular stasis in sickle mice. Infusion of human hemoglobin conjugated with polyethylene glycol and saturated with CO (MP4CO) markedly induced hepatic HO-1 activity and inhibited NF-ĸB activation and H/R-induced microvascular stasis in sickle mice. These effects were mediated by CO; saline or MP4 saturated with O2 (MP4OX) had little to no effect on H/R-induced stasis, though unmodified oxyhemoglobin exacerbated stasis. The HO-1 inhibitor, tin protoporphyrin, blocked MP4CO protection, consistent with HO-1 involvement in the protection afforded by MP4CO. MP4CO also induced nuclear factor-erythroid 2 p45-related factor 2 (Nrf2), an important transcriptional regulator of HO-1 and other antioxidant genes. In a heterozygous (hemoglobin-AS) sickle mouse model, intravenous hemin induced cardiovascular collapse and mortality within 120 minutes, which was significantly reduced by MP4CO, but not MP4OX. These data demonstrate that MP4CO induces cytoprotective Nrf2 and HO-1 and decreases NF-ĸB activation, microvascular stasis, and mortality in transgenic sickle mouse models.
•Carbon monoxide treatment of murine sickle mice can ameliorate inflammation and vaso-occlusion.•MP4CO induces heme oxygenase-1 and Nrf2 to mediate these salutatory effects.</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2013-02-486282</identifier><identifier>PMID: 23908468</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Anemia, Sickle Cell - drug therapy ; Anemia, Sickle Cell - metabolism ; Anemia, Sickle Cell - mortality ; Animals ; Carbon Monoxide - metabolism ; Carbon Monoxide - pharmacology ; Disease Models, Animal ; Female ; Guaiacol - analogs & derivatives ; Heme Oxygenase-1 - metabolism ; Hemin - metabolism ; Hemin - pharmacology ; Hemoglobins - metabolism ; Hemoglobins - pharmacology ; Humans ; Inflammation - drug therapy ; Inflammation - metabolism ; Inflammation - mortality ; Male ; Maleimides - metabolism ; Maleimides - pharmacology ; Membrane Proteins - metabolism ; Mice ; Mice, Transgenic ; Microcirculation - drug effects ; Microcirculation - physiology ; NF-E2-Related Factor 2 - metabolism ; NF-kappa B - metabolism ; Polyethylene Glycols - metabolism ; Polyethylene Glycols - pharmacology ; Vascular Biology ; Vasculitis - drug therapy ; Vasculitis - metabolism ; Vasculitis - mortality</subject><ispartof>Blood, 2013-10, Vol.122 (15), p.2757-2764</ispartof><rights>2013 American Society of Hematology</rights><rights>2013 by The American Society of Hematology 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-300468777d9edb691a49c8773225e92bf5846df3c76de3fb4979182adacf870e3</citedby><cites>FETCH-LOGICAL-c463t-300468777d9edb691a49c8773225e92bf5846df3c76de3fb4979182adacf870e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23908468$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Belcher, John D.</creatorcontrib><creatorcontrib>Young, Mark</creatorcontrib><creatorcontrib>Chen, Chunsheng</creatorcontrib><creatorcontrib>Nguyen, Julia</creatorcontrib><creatorcontrib>Burhop, Kenneth</creatorcontrib><creatorcontrib>Tran, Phuc</creatorcontrib><creatorcontrib>Vercellotti, Gregory M.</creatorcontrib><title>MP4CO, a pegylated hemoglobin saturated with carbon monoxide, is a modulator of HO-1, inflammation, and vaso-occlusion in transgenic sickle mice</title><title>Blood</title><addtitle>Blood</addtitle><description>Transgenic sickle mice expressing βS hemoglobin have activated vascular endothelium in multiple organs that exhibits enhanced expression of NF-ĸB and adhesion molecules and promotes microvascular stasis in sickle, but not normal, mice in response to hypoxia/reoxygenation (H/R), or heme. Induction of heme oxygenase-1 (HO-1) or administration of its products, carbon monoxide (CO) or biliverdin, inhibits microvascular stasis in sickle mice. Infusion of human hemoglobin conjugated with polyethylene glycol and saturated with CO (MP4CO) markedly induced hepatic HO-1 activity and inhibited NF-ĸB activation and H/R-induced microvascular stasis in sickle mice. These effects were mediated by CO; saline or MP4 saturated with O2 (MP4OX) had little to no effect on H/R-induced stasis, though unmodified oxyhemoglobin exacerbated stasis. The HO-1 inhibitor, tin protoporphyrin, blocked MP4CO protection, consistent with HO-1 involvement in the protection afforded by MP4CO. MP4CO also induced nuclear factor-erythroid 2 p45-related factor 2 (Nrf2), an important transcriptional regulator of HO-1 and other antioxidant genes. In a heterozygous (hemoglobin-AS) sickle mouse model, intravenous hemin induced cardiovascular collapse and mortality within 120 minutes, which was significantly reduced by MP4CO, but not MP4OX. These data demonstrate that MP4CO induces cytoprotective Nrf2 and HO-1 and decreases NF-ĸB activation, microvascular stasis, and mortality in transgenic sickle mouse models.
•Carbon monoxide treatment of murine sickle mice can ameliorate inflammation and vaso-occlusion.•MP4CO induces heme oxygenase-1 and Nrf2 to mediate these salutatory effects.</description><subject>Anemia, Sickle Cell - drug therapy</subject><subject>Anemia, Sickle Cell - metabolism</subject><subject>Anemia, Sickle Cell - mortality</subject><subject>Animals</subject><subject>Carbon Monoxide - metabolism</subject><subject>Carbon Monoxide - pharmacology</subject><subject>Disease Models, Animal</subject><subject>Female</subject><subject>Guaiacol - analogs & derivatives</subject><subject>Heme Oxygenase-1 - metabolism</subject><subject>Hemin - metabolism</subject><subject>Hemin - pharmacology</subject><subject>Hemoglobins - metabolism</subject><subject>Hemoglobins - pharmacology</subject><subject>Humans</subject><subject>Inflammation - drug therapy</subject><subject>Inflammation - metabolism</subject><subject>Inflammation - mortality</subject><subject>Male</subject><subject>Maleimides - metabolism</subject><subject>Maleimides - pharmacology</subject><subject>Membrane Proteins - metabolism</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Microcirculation - drug effects</subject><subject>Microcirculation - physiology</subject><subject>NF-E2-Related Factor 2 - metabolism</subject><subject>NF-kappa B - metabolism</subject><subject>Polyethylene Glycols - metabolism</subject><subject>Polyethylene Glycols - pharmacology</subject><subject>Vascular Biology</subject><subject>Vasculitis - drug therapy</subject><subject>Vasculitis - metabolism</subject><subject>Vasculitis - mortality</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UctuFDEQtCIQWQJ_EEX-gBjaj3ldIkWrQJCClgOcLY_ds2syY6_s2U3yF3wyThYCXDi1uuyqru4i5JTDO85b8b4fY3RMAJcMBFNtLVpxRBa8Ei0DEPCCLACgZqpr-DF5nfN3AK6kqF6RYyE7aFXdLsiPz1_UcnVODd3i-mE0Mzq6wSmux9j7QLOZd-kJvPPzhlqT-hjoFEO89w7Pqc-FOUW3K8yYaBzo9YrxgodhNNNkZh9DEQ-O7k2OLFo77nLBygc6JxPyGoO3NHt7OyKdvMU35OVgxoxvf9UT8u3D1dflNbtZffy0vLxhVtVyZhKg-G-axnXo-rrjRnW29FKICjvRD1XZzw3SNrVDOfTlCl25mnHGDm0DKE_IxUF3u-sndBZD8TPqbfKTSQ86Gq__fQl-o9dxrxXUTQWqCKiDgE0x54TDM5eDfkxIPyWkHxPSIPQhoUI7-3vuM-l3JH-MYdl-7zHpbD0Gi84ntLN20f9_wk9eU6U-</recordid><startdate>20131010</startdate><enddate>20131010</enddate><creator>Belcher, John D.</creator><creator>Young, Mark</creator><creator>Chen, Chunsheng</creator><creator>Nguyen, Julia</creator><creator>Burhop, Kenneth</creator><creator>Tran, Phuc</creator><creator>Vercellotti, Gregory M.</creator><general>Elsevier Inc</general><general>American Society of Hematology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20131010</creationdate><title>MP4CO, a pegylated hemoglobin saturated with carbon monoxide, is a modulator of HO-1, inflammation, and vaso-occlusion in transgenic sickle mice</title><author>Belcher, John D. ; Young, Mark ; Chen, Chunsheng ; Nguyen, Julia ; Burhop, Kenneth ; Tran, Phuc ; Vercellotti, Gregory M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-300468777d9edb691a49c8773225e92bf5846df3c76de3fb4979182adacf870e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Anemia, Sickle Cell - drug therapy</topic><topic>Anemia, Sickle Cell - metabolism</topic><topic>Anemia, Sickle Cell - mortality</topic><topic>Animals</topic><topic>Carbon Monoxide - metabolism</topic><topic>Carbon Monoxide - pharmacology</topic><topic>Disease Models, Animal</topic><topic>Female</topic><topic>Guaiacol - analogs & derivatives</topic><topic>Heme Oxygenase-1 - metabolism</topic><topic>Hemin - metabolism</topic><topic>Hemin - pharmacology</topic><topic>Hemoglobins - metabolism</topic><topic>Hemoglobins - pharmacology</topic><topic>Humans</topic><topic>Inflammation - drug therapy</topic><topic>Inflammation - metabolism</topic><topic>Inflammation - mortality</topic><topic>Male</topic><topic>Maleimides - metabolism</topic><topic>Maleimides - pharmacology</topic><topic>Membrane Proteins - metabolism</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Microcirculation - drug effects</topic><topic>Microcirculation - physiology</topic><topic>NF-E2-Related Factor 2 - metabolism</topic><topic>NF-kappa B - metabolism</topic><topic>Polyethylene Glycols - metabolism</topic><topic>Polyethylene Glycols - pharmacology</topic><topic>Vascular Biology</topic><topic>Vasculitis - drug therapy</topic><topic>Vasculitis - metabolism</topic><topic>Vasculitis - mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Belcher, John D.</creatorcontrib><creatorcontrib>Young, Mark</creatorcontrib><creatorcontrib>Chen, Chunsheng</creatorcontrib><creatorcontrib>Nguyen, Julia</creatorcontrib><creatorcontrib>Burhop, Kenneth</creatorcontrib><creatorcontrib>Tran, Phuc</creatorcontrib><creatorcontrib>Vercellotti, Gregory M.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Belcher, John D.</au><au>Young, Mark</au><au>Chen, Chunsheng</au><au>Nguyen, Julia</au><au>Burhop, Kenneth</au><au>Tran, Phuc</au><au>Vercellotti, Gregory M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MP4CO, a pegylated hemoglobin saturated with carbon monoxide, is a modulator of HO-1, inflammation, and vaso-occlusion in transgenic sickle mice</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>2013-10-10</date><risdate>2013</risdate><volume>122</volume><issue>15</issue><spage>2757</spage><epage>2764</epage><pages>2757-2764</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>Transgenic sickle mice expressing βS hemoglobin have activated vascular endothelium in multiple organs that exhibits enhanced expression of NF-ĸB and adhesion molecules and promotes microvascular stasis in sickle, but not normal, mice in response to hypoxia/reoxygenation (H/R), or heme. Induction of heme oxygenase-1 (HO-1) or administration of its products, carbon monoxide (CO) or biliverdin, inhibits microvascular stasis in sickle mice. Infusion of human hemoglobin conjugated with polyethylene glycol and saturated with CO (MP4CO) markedly induced hepatic HO-1 activity and inhibited NF-ĸB activation and H/R-induced microvascular stasis in sickle mice. These effects were mediated by CO; saline or MP4 saturated with O2 (MP4OX) had little to no effect on H/R-induced stasis, though unmodified oxyhemoglobin exacerbated stasis. The HO-1 inhibitor, tin protoporphyrin, blocked MP4CO protection, consistent with HO-1 involvement in the protection afforded by MP4CO. MP4CO also induced nuclear factor-erythroid 2 p45-related factor 2 (Nrf2), an important transcriptional regulator of HO-1 and other antioxidant genes. In a heterozygous (hemoglobin-AS) sickle mouse model, intravenous hemin induced cardiovascular collapse and mortality within 120 minutes, which was significantly reduced by MP4CO, but not MP4OX. These data demonstrate that MP4CO induces cytoprotective Nrf2 and HO-1 and decreases NF-ĸB activation, microvascular stasis, and mortality in transgenic sickle mouse models.
•Carbon monoxide treatment of murine sickle mice can ameliorate inflammation and vaso-occlusion.•MP4CO induces heme oxygenase-1 and Nrf2 to mediate these salutatory effects.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>23908468</pmid><doi>10.1182/blood-2013-02-486282</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-4971 |
ispartof | Blood, 2013-10, Vol.122 (15), p.2757-2764 |
issn | 0006-4971 1528-0020 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4067504 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Anemia, Sickle Cell - drug therapy Anemia, Sickle Cell - metabolism Anemia, Sickle Cell - mortality Animals Carbon Monoxide - metabolism Carbon Monoxide - pharmacology Disease Models, Animal Female Guaiacol - analogs & derivatives Heme Oxygenase-1 - metabolism Hemin - metabolism Hemin - pharmacology Hemoglobins - metabolism Hemoglobins - pharmacology Humans Inflammation - drug therapy Inflammation - metabolism Inflammation - mortality Male Maleimides - metabolism Maleimides - pharmacology Membrane Proteins - metabolism Mice Mice, Transgenic Microcirculation - drug effects Microcirculation - physiology NF-E2-Related Factor 2 - metabolism NF-kappa B - metabolism Polyethylene Glycols - metabolism Polyethylene Glycols - pharmacology Vascular Biology Vasculitis - drug therapy Vasculitis - metabolism Vasculitis - mortality |
title | MP4CO, a pegylated hemoglobin saturated with carbon monoxide, is a modulator of HO-1, inflammation, and vaso-occlusion in transgenic sickle mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A17%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MP4CO,%20a%20pegylated%20hemoglobin%20saturated%20with%20carbon%20monoxide,%20is%20a%20modulator%20of%20HO-1,%20inflammation,%20and%20vaso-occlusion%20in%20transgenic%20sickle%20mice&rft.jtitle=Blood&rft.au=Belcher,%20John%20D.&rft.date=2013-10-10&rft.volume=122&rft.issue=15&rft.spage=2757&rft.epage=2764&rft.pages=2757-2764&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2013-02-486282&rft_dat=%3Celsevier_pubme%3ES0006497120497861%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/23908468&rft_els_id=S0006497120497861&rfr_iscdi=true |